Marker Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Marker Therapeutics generated cash of -$16,439,961, which is more than the previous year. Cash used in financing activities reached the amount of $1,105,117 last year. Net change in cash is therefore $3,329,278.
Cash Flow
| 2014 | -2.18M | 0 | 2.28M |
|---|---|---|---|
| 2015 | -4.34M | 0 | 10.77M |
| 2016 | -6.50M | 0 | 7.78M |
| 2017 | -8.43M | 0 | 5.71M |
| 2018 | -14.47M | -147.66K | 71.24M |
| 2019 | -18.28M | -374.98K | 816.47K |
| 2020 | -18.85M | -10.42M | 6.73M |
| 2021 | -27.27M | -3.13M | 52.55M |
| 2022 | -26.97M | -4.94M | 202.13K |
| 2023 | -16.43M | 18.66M | 1.10M |
MRKR Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 11.78M | 43.49M | 21.35M | 43.90M | 61.74M | 5.12M | 7.85M | 6.57M | 141.94K | 48.58K |
Operating activities | ||||||||||
Net income | -14.04M | -29.93M | -41.87M | -28.70M | -21.42M | -147.95M | -10.98M | -2.45M | -34.06M | -30.88M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 3.68M | 3.16M | 1.07M | 286.58K | 0 | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 858.26K | 3.30M | 5.96M | 5.22M | 5.35M | 0 | 2.73M | 1.55M | 1.70M | 1.39M |
| Deferred income tax benefit | 858.26K | 3.30M | 5.96M | 5.22M | 5.35M | 0 | 2.73M | 1.55M | 1.70M | 1.39M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 1.37M | -2.40M | 1.00M | 55.63K | 51.98K | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 2.40M | -1.00M | -55.63K | -51.98K | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 611.26K | -4.30M | 4.14M | 4.22M | -963.96K | 1.24M | 283.37K | 257.58K | 96.01K | -145.19K |
Cash generated by operating activities | -16.43M | -26.97M | -27.27M | -18.85M | -18.28M | -14.47M | -8.43M | -6.50M | -4.34M | -2.18M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -4.94M | -3.13M | -10.42M | -374.98K | -147.66K | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 18.66M | -4.94M | -3.13M | -10.42M | -374.98K | -147.66K | 0 | 0 | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 1.01M | 202.13K | 52.55M | 6.18M | 816.47K | 66.94M | 5.40M | 0 | 2.46M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | -71.71K | -310.49K | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -388.79K | -173.26K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 1.10M | 202.13K | 52.55M | 6.73M | 816.47K | 71.24M | 5.71M | 7.78M | 10.77M | 2.28M |
Net Change In Cash | 3.32M | -31.71M | 22.14M | -22.55M | -17.84M | 56.61M | -2.72M | 1.27M | 6.43M | 93.35K |
Cash at end of period | 15.11M | 11.78M | 43.49M | 21.35M | 43.90M | 61.74M | 5.12M | 7.85M | 6.57M | 141.94K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |